Below is a look at the 40 best performing stocks in the Russell 3,000 so far this year. The average stock in the index is up 2.8% on the year, and the names below are all up more than 55%. Intercept Pharma (NASDAQ:ICPT) still leads the way by a wide margin with a YTD gain of 388.8%, even though it is down $130 from its recent highs just a few weeks ago. InterMune (NASDAQ:ITMN) ranks second with a gain of 128.8%, followed by Endocyte (NASDAQ:ECYT), Furiex Pharma (NASDAQ:FURX) and Horizon Pharma (NASDAQ:HZNP). It's notable that the five best performers are all biotech names.
Other notable stocks on the list of winners so far this year include magicJack (NASDAQ:CALL), FuelCell Energy (NASDAQ:FCEL), World Wrestling Entertainment (NYSE:WWE), TriQuint Semi (TQNT) and Freescale Semi (NYSE:FSL).
Of the 2,987 stocks in the Russell 3,000 that were trading at the start of the year, 1,338 were down YTD coming into today. Below is a list of the worst performers in the index, which are all down more than 34% YTD. Body Central (OTCQB:BODY) leads the way lower with a decline of 69%, followed by American Apparel (APP) at -60% and Fairway Group (NASDAQ:FWM) at -58%. NII Holdings (NASDAQ:NIHD) and Geron (NASDAQ:GERN) round out the top five on the downside. Other notables on the list of losers include Conn's (NASDAQ:CONN), Aeropostale (NYSE:ARO), ExOne (NASDAQ:XONE), 3D Systems (NYSE:DDD), Weight Watchers (NYSE:WTW), Infoblox (NYSE:BLOX) and Overstock.com (NASDAQ:OSTK).
Editor's Note: This article covers one or more stocks trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the risks associated with these stocks.